Transgenically expressed human delta epithelial sodium channel facilitated fluid absorption in mouse fetal lung explants.

Epithelial sodium channels (ENaCs) are essential for sodium (Na) transport and maintaining fluid balance, which is vital for the removal of fetal fluid at birth and the homeostasis of luminal fluid in the lungs. In mice, ENaC is composed of three subunits (α, β, and γ). However, in humans, a fourth δ-subunit is also expressed. This study investigated the physiological role of the δ-ENaC in fetal/neonatal lungs, an area that remains less explored despite its potential significance. We measured expansion in mouse E15 lung explants expressing human δ-ENaC (SCNN1D-Tg). We found that transgenic expression of δ-ENaC enhanced fluid absorption and significantly reduced the surface area increase compared with wild-type (WT) explants (142.30 ± 5.81% vs. 163.80 ± 5.95% expansion, < 0.001). Amiloride treatments revealed that both α-ENaC and δ-ENaC contributed to fluid absorption. No statistical significance was observed in the amiloride-sensitive fraction of SCNN1D-Tg explants compared with WT preparations in the presence of 100 µM amiloride ( = 0.400). In contrast, a significant reduction in amiloride-sensitive fraction in SCNN1D-Tg explants was observed in the presence of 10 µM amiloride ( < 0.001). Furthermore, specific blocking of α-ENaC using α-13 inhibitory peptide resulted in a 2.12-fold growth increase in WT explants, compared with a 1.47-fold increase in SCNN1D-Tg explants ( < 0.001). In summary, this study provides evidence that δ-ENaC may contribute to fluid absorption in E15 and newborn lungs, highlighting its significance in alveolar fluid regulation in prenatal and postnatal lungs. The findings of our study highlight the significance of δ-ENaC in lung fluid regulation. Transgenic expression of human δ-ENaC contributes to fluid absorption increase, supporting its potential as a pathway for alveolar fluid clearance in E15 and postnatal lungs.